PSNL
Personalis Inc
Halal Rating :
Last Price
$4.89
Last updated:
Market Cap
-
7D Change
-8.6%
1 Year Change
203.73%
Company Overview
Industries
Exchange
Next Earnings Date
Personalis, Inc. is a healthcare company that provides advanced genomic sequencing and analytics solutions. The company specializes in cancer genomics, offering services that help researchers and clinicians better understand and treat various forms of cancer. Their primary products include NeXT Platform, a comprehensive molecular profiling solution, and NeXT Personal, a liquid biopsy test for cancer detection and monitoring.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $25.71m | $40.1m | - | $7000.0 | 0.00% | 0.02% |
| June 30, 2024 | $22.58m | $39.48m | - | $9000.0 | 0.00% | 0.02% |
| March 31, 2024 | $19.52m | $38.41m | - | $9000.0 | 0.00% | 0.02% |
Company Impact
Help us evaluate Personalis Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.